During the past decade, Knappschaftsklinikum Saar GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Knappschaftsklinikum Saar GmbH" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Knappschaftsklinikum Saar GmbH" in a lesser frequency.

Most popular intervention types in "Knappschaftsklinikum Saar GmbH" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Infliximab" (1 trials), "PF-06438179" (1 trials), "PF-06650833" (1 trials), "Placebo" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knappschaftsklinikum Saar GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Knappschaftsklinikum Saar GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Knappschaftsklinikum Saar GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Knappschaftsklinikum Saar GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".